KFSHRC’s cutting-edge genetic screening is saving lives, preventing diseases, and shaping a healthier future for families.
Riyadh
King Faisal Specialist Hospital & Research Centre (KFSHRC) is revolutionising prenatal care with innovation and precision medicine. By screening over 300 genes, KFSHRC has provided early genetic insights to 1,104 pregnant women, preventing 276 genetic disorders and saving the Saudi healthcare system 360 million riyals.
Through its Preventive Fetal Screening Program, KFSHRC identifies genetic risks and delivers targeted care during critical pregnancy stages. Utilising cutting-edge technologies such as Next-Generation Sequencing (NGS) and Non-Invasive Prenatal Testing (NIPT), these advancements enhance diagnostic precision and safety, benefiting 1,500 families annually. The program has also expanded its capacity to detect over 500 additional genetic conditions, empowering families with early knowledge, reducing the incidence of severe genetic disorders, and improving new-born health outcomes.
From genetic screenings to treatments and advanced surgical interventions, KFSHRC remains committed to safeguarding well-being and fostering trust. Recognising its impact, the hospital’s prenatal department received the 2023 Performance Improvement Award for enhancing patient care through accessibility and innovation, shaping a healthier future for families.
KFSHRC has achieved remarkable recognition by being ranked first in the Middle East and Africa and 15th globally on the list of the world’s top 250 Academic Medical Centres for the third consecutive year. It has also been named the most valuable healthcare brand in both the Kingdom and the Middle East, according to the 2025 Brand Finance rankings. Furthermore, in the same year, KFSHRC was recognized among the world’s best 250 hospitals and was included in the World’s Best Smart Hospitals list for 2025 by Newsweek magazine.
